Chilton Capital Management’s Astera Labs ALAB Stock Holding History

Chilton Capital Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33	Closed	-$3.62K	–	692
2026 Q1	$3.62K	Buy	+33	New	+$4.7K	﹤0.01%	564

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chilton Capital Management's ALAB Position: Q2 2026 in Review

Chilton Capital Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 33 shares — an estimated $3.62K sold.

Chilton Capital Management first reported a position in ALAB in Q1 2026 and held it in 1 quarter. The position peaked at $3.62K in Q1 2026. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Chilton Capital Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
Chilton Capital Management sold 33 Astera Labs shares in Q2 2026, an estimated $3.62K.
Chilton Capital Management first reported a position in Astera Labs in Q1 2026 and held it in 1 quarter.
Chilton Capital Management's Astera Labs position peaked at $3.62K in Q1 2026.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.